Arecor Therapeutics
Continued delivery with key AT278 data due in Q423Arecor Therapeutics
Hikma licence milestone achievedArecor Therapeutics
Getting the chemistry rightArecor Therapeutics
Specialty Hospital products formulation collaborationArecor Therapeutics
AT247 Phase I pump data confirms promising profileArecor Therapeutics
Broadening opportunities and preparing for the futureArecor Therapeutics
Key clinical diabetes events on track for H222Arecor Therapeutics
Acquisition of Tetris Pharma and £6m equity raiseArecor Therapeutics
AT278 hits the sweet spotArecor Therapeutics
Ambitious, focussed, and delivering on its promise